Correlation Between Aerovate Therapeutics and Revolution Medicines
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Revolution Medicines, you can compare the effects of market volatilities on Aerovate Therapeutics and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Revolution Medicines.
Diversification Opportunities for Aerovate Therapeutics and Revolution Medicines
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Aerovate and Revolution is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Revolution Medicines go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Revolution Medicines
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the Revolution Medicines. But the stock apears to be less risky and, when comparing its historical volatility, Aerovate Therapeutics is 1.44 times less risky than Revolution Medicines. The stock trades about -0.19 of its potential returns per unit of risk. The Revolution Medicines is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest 4,092 in Revolution Medicines on November 30, 2024 and sell it today you would lose (184.00) from holding Revolution Medicines or give up 4.5% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Aerovate Therapeutics vs. Revolution Medicines
Performance |
Timeline |
Aerovate Therapeutics |
Revolution Medicines |
Aerovate Therapeutics and Revolution Medicines Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aerovate Therapeutics and Revolution Medicines
The main advantage of trading using opposite Aerovate Therapeutics and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.Aerovate Therapeutics vs. Adagene | ||
Aerovate Therapeutics vs. Acrivon Therapeutics, Common | ||
Aerovate Therapeutics vs. Rezolute | ||
Aerovate Therapeutics vs. AN2 Therapeutics |
Revolution Medicines vs. Blueprint Medicines Corp | ||
Revolution Medicines vs. Sana Biotechnology | ||
Revolution Medicines vs. Kymera Therapeutics | ||
Revolution Medicines vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Fundamental Analysis View fundamental data based on most recent published financial statements |